CD33 and neoplasm: We found 1,306 differentially expressed genes (DEGs) between tumor-infiltrating CD33+ cells in CRC patients with early and advanced stages (Log2 FC ≥ 2 and P value cutoff ≤ 0.05, Supplementary Table 1).